Join to View Full Profile
2626 N Webb RdWichita, KS 67226
Phone+1 316-636-6100
Fax+1 316-636-5813
Dr. Joudi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Fadi Joudi is a urology specialist based in Wichita, KS, with subspecialties in minimally invasive surgery and surgical oncology. He completed his residency in urology at the University of Iowa Hospitals and Clinics, following his medical education at the American University of Beirut Faculty of Medicine. He served as an Assistant Professor at the University of Iowa Hospitals & Clinics from 2006 to 2010. Dr. Joudi has expertise in prostate cancer, bladder cancer , benign prostate hyperplasia, kidney stones , incontinence, and male sexual dysfunction. His research includes publications on prostate cancer detection and renal cell carcinoma, with several studies cited extensively. Dr. Joudi has led a Phase 3 clinical trial and has received multiple CMS Meaningful Use certifications.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Urology, 2001 - 2004
American University of Beirut Faculty of MedicineClass of 1998
Certifications & Licensure
KS State Medical License 2010 - 2027
IA State Medical License 2001 - 2011
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification 2011 Pulse Complete EHR, Pulse Systems, Inc, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Pulse Complete EHR, Pulse Systems, Inc, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Pulse Complete EHR, Pulse Systems, Inc, 2012, 2014-2017
Clinical Trials
- A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsThe Role of Multiparametric MRI and MRI-targeted Biopsy in Detecting Clinically Significant Prostate Cancer in the Community Setting: A Retrospective Study.Kenneth E Schmanke, Jordan J Stiverson, Rosalee E Zackula, Serge G Srour, Matthew P Lierz
Reviews in Urology. 2020-01-01 - Mesothelial Inclusions in Pelvic Lymph Nodes Initially Diagnosed as Metastatic Prostate Cancer; the Utility of Second Opinions and Genomic Testing in the Setting of Un...Fadi Joudi, Bela S. Denes, Carolyn Mies, Alan W. Shindel
Urology Case Reports. 2017-01-01 - 33 citationsLower Extremity Neuropathies After Robot-Assisted Laparoscopic Prostatectomy on a Split-Leg TableGökhan Koç, Ngii N Tazeh, Fadi N. Joudi, Howard N. Winfield, Chad R. Tracy
Journal of Endourology. 2012-08-07
Press Mentions
Interferon + BCG May Be an Alternative to Radical CystectomySeptember 30th, 2015
External Links
- wichita Urology Grouphttp://www.wichitaurology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
